Opko Health, Inc.
OPK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000944809
In the last 90 days, Opko Health, Inc. insiders filed 0 open-market purchases and 1 sale; 225 institutions reported holding it in 13F filings for Q3 2026, worth $324.4M in total; no superinvestor holds it.
Holders of 5% or more of OPK
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Opko Health, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Frost Phillip MD Et Al | 13D/A | 34.10%255.4M shares | +1.30 ppfrom 32.80% | Aug 19, 20229 filings | Jul 1, 2026 | SEC |
| Rubric Capital Management LP | 13G/A | 6.03%47.8M shares | – | Nov 13, 20242 filings | Jul 9, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
25 Schedule 13D and 13G filings on Opko Health, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jul 1, 20264:04 PM ET | Frost Phillip MD Et Aland 2 others | 13D/A | 34.10%255.4M shares | +1.30 ppfrom 32.80% | Jun 29, 2026 | SEC |
| Oct 1, 20254:46 PM ET | Frost Phillip MD Et Aland 2 others | 13D/A | 32.80%252.9M shares | +1.10 ppfrom 31.70% | Sep 30, 2025 | SEC |
| Jul 9, 20254:10 PM ET | Rubric Capital Management LPand 1 other | 13G/A | 6.03%47.8M shares | – | Jun 30, 2025 | SEC |
| Apr 3, 20255:22 PM ET | Frost Phillip MD Et Aland 2 others | 13D/A | 31.70%252.4M shares | – | Apr 2, 2025 | SEC |
| Apr 3, 20255:21 PM ET | Hsiao Jane PH Dand 1 other | 13D/A | 4.50%35.7M shares | –Below 5% | Apr 2, 2025 | SEC |
| Nov 15, 2024 | Frost Phillip MD Et Al | 13D/AOld format | – | – | – | SEC |
| Nov 13, 2024 | Rubric Capital Management LP | 13GOld format | – | New | – | SEC |
| Nov 12, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Nov 4, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Aug 29, 2024 | Frost Phillip MD Et Al | 13D/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 24, 2024 | Hsiao Jane PH D | 13D/AOld format | – | – | – | SEC |
| Jan 24, 2024 | Frost Phillip MD Et Al | 13D/AOld format | – | – | – | SEC |
| Jan 22, 2024 | Frost Phillip MD Et Al | 13D/AOld format | – | – | – | SEC |
| Feb 21, 2023 | Frost Phillip MD Et Al | 13D/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Aug 19, 2022 | Hsiao Jane PH D | 13D/AOld format | – | – | – | SEC |
| Aug 19, 2022 | Frost Phillip MD Et Al | 13D/AOld format | – | – | – | SEC |
| Jun 29, 2022 | Zerhouni Elias A. | 13DOld format | – | New | – | SEC |
| Jun 29, 2022 | Nabel Gary J. | 13DOld format | – | New | – | SEC |
| Mar 9, 20225:18 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 1, 20225:08 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 29, 20215:23 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Opko Health, Inc. shares.
No Form 144 notices for Opko Health, Inc. are on file.